Evidence map›Paper›PMID 40943852›Full record

ArticleJournal of clinical medicine2025

Cytoreductive Surgery in Ovarian Cancer: Should the New Optimal Threshold Be 2.5 mm?

Tudor Razvan Grigorie, Gheorghe Potlog, Cosmin Verdea, Teodora Delia Chiriac, George Andrei Popescu, Dana Galieta Minca, Radu Virgil Costea, Dan Brebu, Sorin Tiberiu Alexandrescu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Advances in Gynecological Diseases.Journal of clinical medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tudor Razvan GrigorieCarol Davila University of Medicine and Pharmacy, Dionisie Lupu No. 37, Sector 2, 020021 Bucharest, Romania.
Gheorghe PotlogCenter for Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, 022328 Bucharest, Romania.
Cosmin VerdeaDepartment of Hepato-Bilio-Pancreatic Surgery, Emergency University Hospital Bucharest, Splaiul Independentei 169, Sector 5, 050098 Bucharest, Romania.
Teodora Delia ChiriacCarol Davila University of Medicine and Pharmacy, Dionisie Lupu No. 37, Sector 2, 020021 Bucharest, Romania.
George Andrei PopescuCarol Davila University of Medicine and Pharmacy, Dionisie Lupu No. 37, Sector 2, 020021 Bucharest, Romania.ORCID 0009-0005-1200-0301
Dana Galieta MincaCarol Davila University of Medicine and Pharmacy, Dionisie Lupu No. 37, Sector 2, 020021 Bucharest, Romania.
Radu Virgil CosteaCarol Davila University of Medicine and Pharmacy, Dionisie Lupu No. 37, Sector 2, 020021 Bucharest, Romania.ORCID 0000-0003-0509-693X
Dan Brebu10th Department of General Surgery, Victor Babes University of Medicine and Pharmacy, Piata Eftimie Murgu 2, 300041 Timisoara, Romania.
Sorin Tiberiu AlexandrescuCarol Davila University of Medicine and Pharmacy, Dionisie Lupu No. 37, Sector 2, 020021 Bucharest, Romania.ORCID 0000-0002-2783-2769

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

intraperitoneal hyperthermic chemotherapy (HIPEC)optimal cytoreductive surgeryovarian cancerperitoneal metastasessurvival

Identifiers

PMID40943852
PMCPMC12428847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.